nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aldose reductase inhibition in the treatment of diabetic neuropathy: Where are we in 2004?
|
Gabbay, Kenneth H. |
|
2004 |
|
6 |
p. 405-408 |
artikel |
2 |
An appraisal of aspirin therapy in diabetes
|
Colwell, John A. |
|
2006 |
|
6 |
p. 409-410 |
artikel |
3 |
Anemia and diabetic nephropathy
|
Ritz, Eberhard |
|
2006 |
|
6 |
p. 469-472 |
artikel |
4 |
An update on autonomic neuropathy affecting the gastrointestinal tract
|
Phillips, Liza K. |
|
2006 |
|
6 |
p. 417-423 |
artikel |
5 |
Appropriate drug therapy for improving outcomes in diabetic nephropathy
|
Toto, Robert D. |
|
2002 |
|
6 |
p. 545-552 |
artikel |
6 |
Blood pressure and diabetic nephropathyss
|
Stanton, Robert |
|
2003 |
|
6 |
p. 483-484 |
artikel |
7 |
Blood pressure control—Effects on diabetic nephropathy progression: How low does blood pressure have to be?
|
Newton, Christopher A. |
|
2002 |
|
6 |
p. 530-538 |
artikel |
8 |
Brain effects of leptin: What intracellular mechanism?
|
Rahmouni, Kamal |
|
2003 |
|
6 |
p. 427-429 |
artikel |
9 |
Cardiovascular autonomic neuropathy: Diagnosis and management
|
Vinik, Aaron I. |
|
2006 |
|
6 |
p. 424-430 |
artikel |
10 |
Central nervous system involvement in diabetes mellitus
|
Selvarajah, Dinesh |
|
2006 |
|
6 |
p. 431-438 |
artikel |
11 |
Chronic inflammatory demyelinating polyneuropathy and diabetes
|
Boulton, Andrew J. M. |
|
2003 |
|
6 |
p. 437-438 |
artikel |
12 |
Chronic inflammatory demyelinating polyradiculoneuropathy in diabetes mellitus
|
Ayyar, D. Ram |
|
2004 |
|
6 |
p. 409-412 |
artikel |
13 |
Circadian changes in blood pressure and their relationships to the development of microalbuminuria in type 1 diabetic patients
|
Hogan, Donn |
|
2002 |
|
6 |
p. 539-544 |
artikel |
14 |
Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease
|
Williams, Mark E. |
|
2004 |
|
6 |
p. 441-446 |
artikel |
15 |
Clinical trials report
|
Stanton, Robert C. |
|
2007 |
|
6 |
p. 437-438 |
artikel |
16 |
Clinical trials report
|
Boulton, Andrew J. M. |
|
2004 |
|
6 |
p. 403-404 |
artikel |
17 |
Clinical trials report
|
Boulton, Andrew J. M. |
|
2007 |
|
6 |
p. 407-408 |
artikel |
18 |
Clinic versus home blood pressure measurements in patients with CKD
|
Stanton, Robert |
|
2006 |
|
6 |
p. 453-454 |
artikel |
19 |
Combination use of angiotensin II receptor blocker and ace inhibitor in the treatment of diabetic nephropathy
|
Molitch, Mark E. |
|
2002 |
|
6 |
p. 521-522 |
artikel |
20 |
Contrast-induced nephropathy: Update with special emphasis on patients with diabetes
|
Solomon, Richard |
|
2007 |
|
6 |
p. 454-458 |
artikel |
21 |
Diabetes and depression
|
Lloyd, Cathy E. |
|
2002 |
|
6 |
p. 465-466 |
artikel |
22 |
Diabetes and nephrolithiasis
|
Daudon, Michel |
|
2007 |
|
6 |
p. 443-448 |
artikel |
23 |
Diabetic nephropathy in African-American patients
|
Crook, Errol D. |
|
2004 |
|
6 |
p. 455-461 |
artikel |
24 |
Diabetic Nephropathy: Worldwide epidemic and effects of current treatment on natural history
|
Rossing, Peter |
|
2006 |
|
6 |
p. 479-483 |
artikel |
25 |
Diabetic neuropathy and microcirculation
|
Hile, Chantel |
|
2003 |
|
6 |
p. 446-451 |
artikel |
26 |
Diagnosis and management of diabetic neuropathy
|
Perkins, Bruce A. |
|
2002 |
|
6 |
p. 495-500 |
artikel |
27 |
Early nephropathy in type 1 diabetes: A new perspective on who will and who will not progress
|
Perkins, Bruce A. |
|
2005 |
|
6 |
p. 455-463 |
artikel |
28 |
Etiology and treatment of erectile failure in diabetes mellitus
|
Richardson, Donald |
|
2002 |
|
6 |
p. 501-509 |
artikel |
29 |
Examining diabetic nephropathy through the lens of mouse genetics
|
Breyer, Matthew D. |
|
2007 |
|
6 |
p. 459-466 |
artikel |
30 |
Focal and multifocal neuropathies
|
Malik, Rayaz A. |
|
2002 |
|
6 |
p. 489-494 |
artikel |
31 |
Future treatments for diabetic neuropathy: Clues from experimental neuropathy
|
Calcutt, Nigel A. |
|
2002 |
|
6 |
p. 482-488 |
artikel |
32 |
Gene expression in diabetic nephropathy
|
Hohenadel, Daniela |
|
2004 |
|
6 |
p. 462-469 |
artikel |
33 |
Growth factors and the development of diabetic nephropathy
|
Wolf, Gunter |
|
2003 |
|
6 |
p. 485-490 |
artikel |
34 |
Healing the diabetic wound and keeping it healed: Modalities for the early 21st century
|
Claxton, Matthew J. |
|
2002 |
|
6 |
p. 510-518 |
artikel |
35 |
Inflammation and diabetic nephropathy
|
Mora, Carmen |
|
2006 |
|
6 |
p. 463-468 |
artikel |
36 |
Intensive treatment of diabetic nephropathy
|
Stanton, Robert |
|
2004 |
|
6 |
p. 433-434 |
artikel |
37 |
Is this bone infected or not? Differentiating neuro-osteoarthropathy from osteomyelitis in the diabetic foot
|
Berendt, Anthony R. |
|
2004 |
|
6 |
p. 424-429 |
artikel |
38 |
Lipids and diabetic nephropathy
|
Rosario, Rey F. |
|
2006 |
|
6 |
p. 455-462 |
artikel |
39 |
Lipids and diabetic renal disease
|
Cooper, Mark E. |
|
2005 |
|
6 |
p. 445-448 |
artikel |
40 |
Literatuer alert
|
|
|
2004 |
|
6 |
p. 399-400 |
artikel |
41 |
Literature alert
|
|
|
2002 |
|
6 |
p. 469-471 |
artikel |
42 |
Literature alert
|
|
|
2003 |
|
6 |
p. 431-433 |
artikel |
43 |
Management of painful diabetic neuropathy: What is new or in the pipeline for 2007?
|
Ziegler, Dan |
|
2007 |
|
6 |
p. 409-415 |
artikel |
44 |
Microalbuminuria as a target to improve cardiovascular and renal outcomes in diabetic patients
|
Basi, Seema |
|
2007 |
|
6 |
p. 439-442 |
artikel |
45 |
Microalbuminuria is a poor predictor for progression of diabetic kidney disease in young type 1 diabetic patients
|
Stanton, Robert |
|
2005 |
|
6 |
p. 443-444 |
artikel |
46 |
Negative pressure wound therapy: Evidence-based treatment for complex diabetic foot wounds
|
Suess, Jennifer J. |
|
2006 |
|
6 |
p. 446-450 |
artikel |
47 |
Neuropathy associated with prediabetes: What is new in 2007?
|
Singleton, J. Rob |
|
2007 |
|
6 |
p. 420-424 |
artikel |
48 |
Newer agents for the treatment of painful diabetic peripheral neuropathy
|
Freeman, Roy |
|
2005 |
|
6 |
p. 409-416 |
artikel |
49 |
New treatments for diabetic neuropathic foot ulceration: Views from a wound healing unit
|
Williams, Dean T. |
|
2003 |
|
6 |
p. 468-474 |
artikel |
50 |
New treatments for diabetic neuropathy: Pathogenetically oriented treatment
|
Bierhaus, Angelika |
|
2003 |
|
6 |
p. 452-458 |
artikel |
51 |
New treatments for diabetic neuropathy: Symptomatic treatments
|
Krishnan, Singhan T. M. |
|
2003 |
|
6 |
p. 459-467 |
artikel |
52 |
Obesity, diabetes, and chronic kidney disease
|
Eknoyan, Garabed |
|
2007 |
|
6 |
p. 449-453 |
artikel |
53 |
Opioids for painful diabetic neuropathy
|
Boulton, Andrew J. M. |
|
2005 |
|
6 |
p. 407-408 |
artikel |
54 |
Pathogenesis of pain in peripheral diabetic neuropathy
|
Calcutt, Nigel A. |
|
2007 |
|
6 |
p. 429-434 |
artikel |
55 |
Pathogenic role of nitric oxide alterations in diabetic nephropathy
|
Prabhakar, Sharma S. |
|
2005 |
|
6 |
p. 449-454 |
artikel |
56 |
PPAR-γ agonists and diabetic nephropathy
|
Zhang, Yahua |
|
2005 |
|
6 |
p. 470-475 |
artikel |
57 |
Proteinuria in diabetic nephropathy: Treatment and evolution
|
Campbell, Ruth C. |
|
2003 |
|
6 |
p. 497-504 |
artikel |
58 |
Proteomics and diabetic nephropathy
|
Merchant, Michael L. |
|
2005 |
|
6 |
p. 464-469 |
artikel |
59 |
Recent developments in the assessment of efficacy in clinical trials of diabetic neuropathy
|
Mojaddidi, Moaz |
|
2005 |
|
6 |
p. 417-422 |
artikel |
60 |
Reducing the incidence of foot ulceration and amputation in diabetes
|
Bartus, Cynthia L. |
|
2004 |
|
6 |
p. 413-418 |
artikel |
61 |
Research development in the pathogenesis of neuropathic diabetic foot ulceration
|
Piaggesi, Alberto |
|
2004 |
|
6 |
p. 419-423 |
artikel |
62 |
Statin therapy in renal disease: Harmful or protective?
|
McCullough, Peter A. |
|
2007 |
|
6 |
p. 467-473 |
artikel |
63 |
Targeting skeletal muscle AMP-activated protein kinase to treat type 2 diabetes
|
Taylor, Eric B. |
|
2007 |
|
6 |
p. 399-401 |
artikel |
64 |
Temperature monitoring to assess, predict, and prevent diabetic foot complications
|
Lavery, Lawrence A. |
|
2007 |
|
6 |
p. 416-419 |
artikel |
65 |
The diabetic foot: The importance of biofilms and wound bed preparation
|
Davis, Stephen C. |
|
2006 |
|
6 |
p. 439-445 |
artikel |
66 |
The epidemiology of neuropathic foot ulcers in individuals with diabetes
|
Sosenko, Jay |
|
2002 |
|
6 |
p. 477-481 |
artikel |
67 |
The International Consensus and practical guidelines on the management and prevention of the diabetic foot
|
Schaper, Nicolaas C. |
|
2003 |
|
6 |
p. 475-479 |
artikel |
68 |
2005: The International Diabetes Federation focuses on the diabetic foot
|
Bakker, Karel |
|
2005 |
|
6 |
p. 436-440 |
artikel |
69 |
The metabolic syndrome and type 2 diabetes: What has gone wrong in type 2 diabetes care?
|
Waldhäusl, Werner K. |
|
2004 |
|
6 |
p. 395-396 |
artikel |
70 |
Theories concerning the pathogenesis of the acute Charcot foot suggest future therapy
|
Jeffcoate, William J. |
|
2005 |
|
6 |
p. 430-435 |
artikel |
71 |
The pivotal role of offloading in the management of neuropathic foot ulceration
|
Wu, Stephanie C. |
|
2005 |
|
6 |
p. 423-429 |
artikel |
72 |
Therapeutic footwear in diabetes
|
Boulton, Andrew J. M. |
|
2002 |
|
6 |
p. 475-476 |
artikel |
73 |
The relationship between glucose control and the development and progression of diabetic nephropathy
|
Phillips, Carrie A. |
|
2002 |
|
6 |
p. 523-529 |
artikel |
74 |
The role of inflammation as a pathogenic factor in the development of renal disease in diabetes
|
Mora, Carmen |
|
2005 |
|
6 |
p. 399-401 |
artikel |
75 |
The role of renal proximal tubular cells in diabetic nephropathy
|
Phillips, Aled O. |
|
2003 |
|
6 |
p. 491-496 |
artikel |
76 |
The step-by-step program for reducing diabetic foot problems: A model for the developing world
|
Pendsey, Sharad |
|
2007 |
|
6 |
p. 425-428 |
artikel |
77 |
Transforming growth factor-beta: A clinical target for the treatment of diabetic nephropathy
|
McGowan, Tracy A. |
|
2004 |
|
6 |
p. 447-454 |
artikel |
78 |
Transplantation for type 1 diabetes: Whole organ pancreas and islet cells
|
Pavlakis, Martha |
|
2006 |
|
6 |
p. 473-478 |
artikel |
79 |
Treatment of prediabetic neuropathy
|
Boulton, Andrew J. M. |
|
2006 |
|
6 |
p. 415-416 |
artikel |
80 |
Update on the pathogenesis of diabetic neuropathy
|
Obrosova, Irina G. |
|
2003 |
|
6 |
p. 439-445 |
artikel |
81 |
Use of genetic mouse models in the study of diabetic nephropathy
|
Allen, Terri J. |
|
2004 |
|
6 |
p. 435-440 |
artikel |
82 |
Web alert
|
|
|
2007 |
|
6 |
p. 402-403 |
artikel |
83 |
Web alert
|
|
|
2002 |
|
6 |
p. 467-468 |
artikel |
84 |
Web alert
|
|
|
2005 |
|
6 |
p. 402-403 |
artikel |
85 |
Web alert
|
|
|
2004 |
|
6 |
p. 397-398 |
artikel |
86 |
Web alert
|
|
|
2006 |
|
6 |
p. 411-412 |
artikel |